CLAUDINE J ISAACS

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WASHINGTON, DC NPI 1164414751

General Payments — all program years on this page

$261,226.90

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 189
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $23,155.86 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Genentech USA, Inc. $8,703.317
NOVARTIS PHARMACEUTICALS CORPORATION $4,480.702
PFIZER INC. $4,327.272
Gilead Sciences, Inc. $3,509.584
Merck Sharp & Dohme Corporation $2,135.001

By program year

Program yearAmountRecords
2018 $64,590.8050
2019 $83,891.4768
2020 $18,910.6118
2021 $21,417.928
2022 $34,929.5013
2023 $14,330.7416
2024 $23,155.8616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086918711 Novartis Pharmaceuticals Corporation $80.70 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086918731 Novartis Pharmaceuticals Corporation $4,400.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131358730 PFIZER INC. $4,125.00 07/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1131586436 PFIZER INC. $202.27 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132991067 Genentech USA, Inc. $760.00 10/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1132991071 Genentech USA, Inc. $336.55 03/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132991076 Genentech USA, Inc. $112.06 03/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132991080 Genentech USA, Inc. $130.89 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132991084 Genentech USA, Inc. $315.09 03/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132991088 Genentech USA, Inc. $208.72 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132991092 Genentech USA, Inc. $6,840.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133599319 Gilead Sciences, Inc. $2,880.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133599321 Gilead Sciences, Inc. $480.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133795179 Gilead Sciences, Inc. $115.87 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133866077 Gilead Sciences, Inc. $33.71 06/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141685783 Merck Sharp & Dohme LLC $2,135.00 01/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.